Home » Topics » BioWorld Science, Respiratory

BioWorld Science, Respiratory
RSS

Chiesi Farmaceutici discloses new ROCK inhibitors

July 12, 2022

Aramchol shows effects in preclinical models of lung and gastrointestinal fibrosis

July 8, 2022

New ROCK-1/2 inhibitors identified at Chiesi Farmaceutici

July 8, 2022

Hangzhou Purplecrystal Pharma, Hangzhou Innogate Pharma describe GLS1 inhibitors

July 7, 2022

University of Queensland, James Cook University describe new therapeutic peptides

July 5, 2022

Reistone Biopharma divulges new CatC inhibitors

June 30, 2022

New P2X purinoceptor 3 antagonists discovered at Chiesi

June 23, 2022

Carbon Biosciences raises series A financing to advance cystic fibrosis program toward clinic

June 22, 2022

New phosphodiesterase PDE4B1 inhibitors discovered at Reistone Biopharma

June 21, 2022

Vertex Pharmaceuticals discloses new CFTR modulators

June 17, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 9, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...